Martine Chamuleau

DR., PhD, (Principal Investigator)

1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

M.E.D. Chamuleau, MD PhD is an internist-hematologist with specific expertise in aggressive B-cell Non-Hodgkin lymphoma.

Regarding clinical research: she is the principal investigator of 3 clinical interventional HOVON trials for patients with MYC-driven lymphoma such as double hit lymphoma and Burkitt lymphoma (HOVON 127, 130 and 152). She is also the principal investigator of 2 non-interventional HOVON studies (HOVON 900 and 902) and supervising population-based research on lymphoma in collaboration with the IKNL (PhD D. Issa).

Regarding pre-clinical research she focuses on improving immuno-chemotherapy in aggressive B-cell Non-Hodgkin lymphomas by using hexabodies and duobodies (PhD  H. van der Horst) and by MYC modulation (PhD A.V. de Jonge).

Specialisation

Hematology (aggressive B-cel Non-Hodgkin Lymphoma)

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.
If you made any changes in Pure these will be visible here soon.